Day: January 8, 2025

Dovre Group Plc                Inside information                January 8, 2025, at 5.15 pm Dovre’s subsidiary Suvic Oy has signed a conditional EPC contract for the construction of a 100 megawatt-peak solar park in Finland Suvic has signed a conditional contract for the construction of a 100 MWp solar park in Finland. The agreement is conditional upon the “Notice to Proceed” (NTP), expected in late February 2025. The value of the contract is approximately €55 million. The contract covers the EPC project for the solar park and substation on a turnkey basis. Construction is estimated to begin in March 2025, and the park will be handed over to the client during the autumn of 2026. Suvic has strong experience in building industrial-scale solar parks in Finland. The company has constructed a 32 MW solar power plant in Lakari, Rauma,...

SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement  (the “Agreement”)  with Alpha Cognition Inc. (“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or  the “Product”)  for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is entitled to an exclusive right to develop, register, manufacture, import, export and commercialize the Product in Asia (excluding Japan), Australia and New Zealand (the “Territory”), Alpha reserves the right to manufacture and supply in the Territory. The term of cooperation...

Last patient completed 1 year follow-up of study ALA-BCC-CT013 in December 2024. Data from follow-up will be included in FDA submission, expected in Q3 2025. Biofrontera announced highly statistically significant results for all primary and secondary endpoints (p

Geneva, Switzerland, Jan. 08, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that the post-quantum cryptography (PQC) market is poised for rapid growth as enterprises and governments urgently seek solutions to protect critical infrastructure from future quantum threats. PQC companies like SEALSQ and its parent company, WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY), a global leader in cybersecurity, digital identity, and IoT solutions platform, are at the forefront of this transformation, delivering advanced quantum-resistant solutions to safeguard data and systems today against the quantum challenges of tomorrow. This comes amid...

Latest Partnership Reinforces Vislink’s Position as an Innovation Leader in Advanced Media Solutions Across Asia-Pacific Mt. Olive, New Jersey, Jan. 08, 2025 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (NASDAQ: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the defense, public safety and broadcast sectors, announced its latest partnership with Radio Television Malaysia (RTM) to deploy an advanced Vislink system in a significant infrastructure upgrade of RTM’s Kuala Lumpur Tower facilities. The contract is worth over $1million. This project features the deployment of Vislink’s groundbreaking 4K UHD portable IP-based transmission solution, incorporating the Quantum Encoder and high-speed, bi-directional IP links. This state-of-the-art setup will empower...

EVANSVILLE, Ind., Jan. 08, 2025 (GLOBE NEWSWIRE) — (NASDAQ: ONB) – Old National Bancorp (“Old National”), the holding company of Old National Bank, today announced the following schedule for its fourth-quarter and full-year 2024 earnings release and conference call:Earnings Release: Tuesday, January 21, 2025, at approximately 7:00 A.M. ET   Conference Call: Tuesday, January 21, 2025, at 10:00 A.M. ET   Dial-in Numbers: U.S. (800) 715-9871; International: (646) 307-1963; Access code 9682197   Webcast: Via Old National’s Investor Relations website at oldnational.com   Webcast Replay: Available approximately one hour after completion of the call, until midnight ET on January 20, 2026, via Old National’s Investor Relations website at oldnational.com   Telephone Replay: U.S. (800) 770-2030; International:...

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan. 08, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced that Jedd Comiskey, Senior Vice President, Head of Europe of Outlook Therapeutics, participated in a Virtual Investor “What This Means” segment. As part of the segment, Mr. Comiskey discussed that the National Institute for Health and Care Excellence (NICE) has recommended...

HERNDON, Va., Jan. 08, 2025 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) will host an audio webcast to review its 2024 fourth quarter and year-end financial results on Wednesday, Jan. 29, 2025, at 8:00 a.m. Eastern Time. The results are scheduled to be released the same day by 7:00 a.m. on Navient.com/investors. In addition to being available on the company’s investor website, the results will be filed with the SEC on a Form 8-K available at SEC.gov. The webcast and presentation slides also will be available on Navient.com/investors. Analysts and investors who wish to ask questions are requested to pre-register anytime ahead of the webcast or at least 15 minutes ahead of start time to receive their personal dial-in access details. Others who wish to join in listen-only mode do not need to pre-register and may simply visit the company’s...

XIAMEN, China, Jan. 08, 2025 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that it has entered into securities purchase agreements with several institutional investors to purchase an aggregate of 55,950,000 Ordinary Shares (the “Ordinary Shares”) in a registered direct offering. The Ordinary Shares are being sold at an offering price of $0.07 per share. The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3.9 million before deducting the placement agent’s fees and other estimated offering expenses payable by the Company. The offering is expected to close on or about January 10, 2025, subject to the satisfaction of customary closing conditions. Maxim Group LLC is acting as the sole placement agent...